BR
BlackRock, Inc. disclosed a 10% stake in BMRN
BlackRock, Inc. reported owning 10% of Biomarin Pharmaceutical Inc (BMRN) (19,373,309 shares) in a Schedule 13G filed Nov 4, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 4, 2026
- Source
- Schedule 13G